Schedule

Print

This is the schedule from 2015. 2018 schedule not yet available.

Thursday, October 22, 2015
6:45am to 7:45am Registration and Breakfast
7:45am to 8:00am Seating
8:00am to 8:15am Welcome and Course Objectives

Samuel Z. Goldhaber, MD; Paul M Ridker, MD, MPH; Arthur Sasahara, MD

8:15am to 8:40am Atherothrombosis: Etiology, Pathophysiology, and Template for Therapy

Peter Libby, MD

8:40am to 8:50am Discussion, Q&A
8:50am to 9:15am Inflammation and Atherothrombosis: Where Are We Going?

Paul M Ridker, MD, MPH

9:15am to 9:25am Discussion, Q&A
9:25am to 9:50am Neutrophil Extracellular Traps in VTE: A Link Between Inflammation and Thrombosis

Richard N. Mitchell, MD, PhD

9:50am to 10:00am Discussion, Q&A
10:00am to 10:25am Hypercoagulability: When Should We Test to Influence Management and When Is Testing Warranted Simply to Satisfy Curiosity?

Jean Connors, MD

10:25am to 10:35am Discussion, Q&A
10:35am to 10:55am Coffee Break
10:55am to 11:20am Diagnosis of DVT and PE: An Evidence-Based Approach to Streamline Testing

Henri Bounameaux, MD

11:20am to 11:30am Discussion, Q&A
11:30am to 11:55am Parenteral and Oral Anticoagulants to Treat DVT and PE

Jeff Weitz, MD

11:55am to 12:05pm Discussion, Q&A
12:05pm to 1:05pm Lunch Break
1:05pm to 1:30pm Post-Thrombotic Syndrome/Chronic Venous Insufficiency: Impact on Quality of Life and Potential Prevention with Thrombolytic Therapy

Suresh Vedantham, MD

1:30pm to 1:40pm Discussion, Q&A
1:40pm to 2:05pm DVT Pharmacomechanical Therapy in the Interventional Laboratory--Indications for Advanced Therapy and the Available Drugs and Devices

Suresh Vedantham, MD

2:05pm to 2:15pm Discussion, Q&A
2:15pm to 2:40pm PE Pharmacomechanical Therapy: Focus on Ultrasound-Assisted Low-Dose Catheter Directed Fibrinolysis

Gregory Piazza, MD, MS

2:40pm to 2:50pm Discussion, Q&A
2:50pm to 3:15pm IVC Filters: Rates of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices

Suresh Vedantham, MD

3:15pm to 3:25pm Discussion, Q&A
3:25pm to 3:50pm PE: Pulmonary Pathophysiological and Cardiopulmonary Exercise Testing

C. Gregory Elliott, MD

3:50pm to 4:00pm Discussion, Q&A
4:00pm to 4:20pm Coffee Break
4:20pm to 4:45pm Vascular Diagnostic Laboratory: Upper and Lower Extremity DVT, including Isolated Calf DVT and Iliac Vein DVT as well as Conditions Mimicking DVT

Michael Jaff, DO

4:45pm to 4:55pm Discussion, Q&A
4:55pm End of day's program at Fairmont Copley Plaza

Special Evening Program

6:30pm to 8:15pm Keynote Address by Eugene Braunwald, MD (Dinner provided)

Join your colleagues for a presentation from world-renowned cardiologist Eugene Braunwald, MD, followed by dinner.

Bornstein Amphitheater, Brigham and Women's Hospital

8:15pm Adjourn
Friday, October 23, 2015
7:00am to 7:45am Breakfast
7:45am to 8:00am Seating
8:00am to 8:25am Genetics of Arterial and Venous Thrombosis

Sekar Kathiresan, MD

8:25am to 8:35am Discussion, Q&A
8:35am to 9:00am Genetics, Thrombosis, and Personalized Medicine

Calum A. MacRae, MD, PhD

9:00am to 9:10am Discussion, Q&A
9:10am to 9:35am Lipid Biology and Recent Randomized Controlled Trials

Paul M Ridker, MD, MPH

9:35am to 9:45am Discussion, Q&A
9:45am to 10:10am Updated Lipid Guidelines

Donna M. Polk, MD, MPH

10:10am to 10:20am Discussion, Q&A
10:20am to 10:40am Coffee Break
10:40am to 11:05am Antiplatelet Therapy: Understanding the Options Available when Prescribing Dual Antiplatelet Therapy: Dose, Duration, Reversibility, Bleeding Profiles

Jessica L. Mega, MD, MPH

11:05am to 11:15am Discussion, Q&A
11:15am to 11:40am Dual Antiplatelet Therapy in Coronary Artery Stenting

Laura Mauri, MD

11:40am to 11:50am Discussion, Q&A
11:50am to 12:15pm Stroke Prevention in Atrial Fibrillation: Risk Stratification and Oral Anticoagulants

Samuel Z. Goldhaber, MD

12:15pm to 12:25pm Discussion, Q&A
12:25pm to 12:50pm Stroke Prevention in Atrial Fibrillation: Biomarkers, Genetics, and Drug Levels for Dose Titration of Novel Oral Anticoagulants

Christian T. Ruff, MD, MPH

12:50pm to 1:00pm Discussion, Q&A
1:00pm to 2:00pm Lunch Break
2:00pm to 2:25pm Devices (such as Watchman) for Stroke Prevention in Atrial Fibrillation

Deepak Bhatt, MD, MPH

2:25pm to 2:35pm Discussion, Q&A
2:35pm to 3:00pm Insertable Cardiac Long-Term Monitors to Detect Atrial Fibrillation after Stroke: Indications and Implications

Christine M. Albert, MD, MPH

3:00pm to 3:10pm Discussion, Q&A
3:10pm to 3:35pm Chronic Thromboembolic Pulmonary Hypertension

Aaron Waxman, MD

3:35pm to 3:45pm Discussion, Q&A
3:45pm to 4:10pm VTE in Cancer: Role of LMWH and Optimal Duration of Anticoagulation

Craig Kessler, MD

4:10pm to 4:20pm Discussion, Q&A
4:20pm to 4:45pm VTE in Pregnancy: Prevention, Treatment, Role (if any) of Testing for Hypercoagulability

Shannon Bates, MD

4:45pm to 4:55pm Discussion, Q&A
4:55pm to 5:00pm Closing Remarks
5:00pm Adjourn